Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

GE Healthcare’s SenoClaire to Invigorate US Breast Tomosynthesis Market

September 16, 2014 By GlobalData

The recent approval of GE Healthcare’s SenoClaire by the US Food and Drug Administration (FDA) will end Hologic’s monopoly of the US digital breast tomosynthesis (DBT) market, offering greater choice for hospitals and patients, according to an analyst with research and consulting firm GlobalData.

Niharika Midha, MSc, GlobalData’s Analyst covering Medical Devices, says that SenoClaire has become only the second DBT system available in the US and will compete directly with Hologic’s pioneer product, Selenia Dimensions, which has controlled the market since 2011.

According to GlobalData’s estimates, the US is expected to see a significant rise in DBT unit sales, with a Compound Annual Growth Rate (CAGR) of 36.4% between 2013 and 2020. In addition, DBT is expected to contribute a massive 82% towards US breast imaging market revenues by 2020, making this a highly lucrative space for diagnostic imaging players.

Midha explains: “Due to this positive outlook, other companies are also working towards FDA approval for their DBT systems. For example, Siemens Healthcare filed an application for its system, Mammomat Inspiration with DBT option, in June this year.”

The analyst notes that the two approved DBT devices differ significantly in their mechanisms of acquiring 3D datasets. Selenia Dimensions acquires 15 images over a 15-degree scan angle, and is capable of providing both 3D mediolateral oblique (MLO) and 3D craniocaudal (CC) views of the breast, while GE Healthcare’s SenoClaire captures nine images over 25 degrees to form a 3D MLO view of the breast. It is unclear whether this device also allows acquisition of a 3D CC view.

In addition, Selenia Dimensions uses a continuous tube motion to capture images, while SenoClaire uses a step-and-shoot motion for the X-ray tube, meaning that the gantry comes to a full halt at every X-ray exposure.

Midha continues: “This could mean a higher scan time with SenoClaire than with Selenia Dimensions for the same breast views. It is important to note, however, that a higher scan time does not necessarily mean increased radiation exposure.

“Irrespective of the differences between the products, GlobalData believes that long-term success will come down to targeted marketing and strategic pricing.”

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech